Target intelligence / Profile preview

Pyruvate dehydrogenase phosphatase regulatory subunit (PDPR)

Target
PDPR
Molecular classification
Enzyme regulator, Mitochondrial protein, Other
01

Overview

Pyruvate dehydrogenase phosphatase regulatory subunit (PDPR) is the regulatory subunit of the mitochondrial pyruvate dehydrogenase phosphatase (PDP) complex, which dephosphorylates and activates the pyruvate dehydrogenase (PDH) complex[1][2][3][4]. PDPR is a flavoprotein that modulates the catalytic activity of PDP1 by decreasing its sensitivity to magnesium ions, a regulation that can be reversed by the polyamine spermine[1][3]. PDPR thereby plays a critical role in controlling the entry of glycolytic carbon into the tricarboxylic acid (TCA) cycle and fatty acid synthesis, linking the regulation of glucose metabolism to mitochondrial energy production[1][2][3][4]. PDPR gene variants have been implicated in rare familial phenotypes of limb-girdle muscular dystrophy and papillary thyroid cancer, where loss-of-function leads to metabolic dysregulation and may contribute to tumorigenesis[3][4]. While its precise mechanism in disease remains under investigation, available data support a possible tumor suppressor function for PDPR in glucose metabolism–dependent tissues[4]. PDPR is not currently considered a therapeutic target, and no drugs are known to modulate its function directly[3][4]. Key attributes: - FAD-containing mitochondrial regulatory protein[1][3] - Controls the reactivation of PDH by enabling PDP to dephosphorylate E1α subunit[2][4] - Regulates carbohydrate oxidation and mitochondrial energy flux[1][3] - Loss associated with enhanced phosphorylation of PDH, impaired mitochondrial function, and increased aerobic glycolysis in tumor cells[4]

Other names
PDPrPDP3KIAA1990pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial
02

Biological functions

Regulation of pyruvate dehydrogenase complex (PDC) activityModulation of glucose metabolismRegulation of mitochondrial energy production
03

Disease associations

Cancer (proposed tumor suppressor, especially in thyroid and parotid cancer)Limb-girdle muscular dystrophy (association reported)Other (potential link to metabolic diseases, based on its pathway roles)

Beyond the preview

Go deeper on Pyruvate dehydrogenase phosphatase regulatory subunit (PDPR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyruvate dehydrogenase phosphatase regulatory subunit (PDPR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call